Skip to main content
. 2023 Mar 10;18(3):e0283024. doi: 10.1371/journal.pone.0283024

Fig 2. The combined SCID, SMA and SCD screening.

Fig 2

Between July 1, 2021 and March 31, 2022, a total of 96,015 newborns were screened with a multiplex qPCR assay for SCID, SMA, and SCD. By the end of this period, a total of two SCID, one non-SCID syndromal lymphopenia,14 SMA, and 22 SCD patients were identified, * X = DPunjab, E, or OArab; ** one preterm patient was recalled. The figure was created with InkScape (v. 1.2).